If your heavy menstrual periods get in the way of your daily activities each month, you could have a medical condition called Heavy Monthly Bleeding (HMB). HMB is a treatable condition that affects millions of women.^1,2

These monthly periods can be disruptive, annoying, and can keep you from going about your regular daily routine. They may influence your decisions on whether to go out, what you do, and even what clothing you wear.

Many women believe they have no choice but to live with heavy periods because:

• They think their monthly bleeding is normal for them
• They didn't know that treatment options for heavy periods were available or
• The available options—such as taking hormonal birth control pills or having medical procedures—were not acceptable to them

But there is a non-hormonal choice for women with heavy monthly periods. It’s called LYSTEDA^® (tranexamic acid) tablets. LYSTEDA is a non-hormonal prescription drug FDA approved to treat Heavy Monthly Bleeding. And it significantly lightens periods without hormones or medical procedures.

Ask your healthcare professional about non-hormonal LYSTEDA, and find out if LYSTEDA is right for you.

LYSTEDA^® (tranexamic acid) tablets is a prescription medicine used to treat your heavy monthly period (menstruation) when your bleeding gets in the way of social, leisure and physical activities. LYSTEDA does not contain any hormones and is taken only during your period. It does not treat premenstrual symptoms, does not affect your fertility, and cannot be used as birth control. It does not protect against sexually transmitted diseases.

LYSTEDA has not been studied in adolescents younger than 18 years of age.

Important Safety Information

You should not take LYSTEDA if you currently have or have ever had a blood clot, have been told you are at risk for having a blood clot, or are allergic to LYSTEDA or tranexamic acid.

LYSTEDA can cause serious side effects, including:

• The risk of serious blood clots may be increased when LYSTEDA is taken with hormonal contraceptives, especially if you are taking higher than your normal dose of birth control, are overweight, or if you smoke cigarettes. Risk of serious blood clots may also be increased if you take LYSTEDA with medicines used to help your blood clot or some medicines used to treat leukemia.
• Stop taking LYSTEDA and promptly report any eye problems to your healthcare provider.
• If you have shortness of breath and your throat feels tight, stop taking LYSTEDA and get medical help right away.

Before taking LYSTEDA, tell your healthcare provider about all of your medical conditions, including whether: you have ever had a blood clot or been told that you are at risk of having a blood clot, you are using a form of birth control that contains hormones, you are pregnant or think you may be pregnant, you are breastfeeding or plan to breast-feed, the time between the start of your periods is less than 21 days or more than 35 days, or you have any other medical conditions.

Tell your healthcare provider about all the medicines you take, especially if you take: birth control pills or other hormonal birth control, medicines used to help your blood clot, medicines used to break up blood clots, or any medicines to treat leukemia.

The most common side effects of LYSTEDA include: headaches, sinus and nasal problems, back pain, pain in your abdomen, pain in your muscles or joints, anemia, and fatigue.

If you notice a change in your usual bleeding pattern that worries you, or your heavy bleeding continues, contact your healthcare provider right away. This may be a sign of a more serious condition.

You are encouraged to report side effects of prescription drugs. Contact Ferring at 1-888-FERRING (1-888-337-7464) or call 1-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Full Prescribing Information »

References:
¹ U.S. Census Bureau, 2006-2008 American Community Survey. Available at: http://factfinder.census.gov. Accessed April 7, 2010. ² Tufts Medical Center website. Heavy Menstrual Bleeding. Available at: . Accessed April 7, 2010

LYSTEDA^® (tranexamic acid) tablets, is the only hormone-free FDA-approved prescription medicine that specifically works to lighten Heavy Monthly Bleeding. LYSTEDA helps restore a natural process in your body to reduce the excessive bleeding of your heavy period.

• LYSTEDA is shown to help significantly reduce Heavy Monthly Bleeding*
• Unlike birth control pills, LYSTEDA is taken only during your period, for up to 5 days
• LYSTEDA is shown to work from the first period it is taken
• LYSTEDA reduces your flow without hormones or birth control pills
• LYSTEDA is not birth control and doesn't affect fertility
• LYSTEDA will not change your body's natural hormonal balance
• LYSTEDA is not associated with weight gain

Women taking LYSTEDA had fewer limitations in daily activities during their heavy periods, such as:

• Physical activities (like running, biking, or swimming)
• Social activities (like going to dinner or to the movies)
• Leisure activities (like dancing, golfing, or gardening)

If you have heavy monthly bleeding and are looking for lighter periods without hormones or medical procedures, ask your healthcare professional about non-hormonal LYSTEDA, and whether LYSTEDA is right for you.

*LYSTEDA was consistently effective in clinical trials across every month it was studied, including the very first month. In two clinical studies LYSTEDA reduced Heavy Monthly Bleeding by 38% and 39% compared with 12% and 5% with placebo (sugar pills). Individual results may vary.

LYSTEDA^® (tranexamic acid) tablets is a prescription medicine used to treat your heavy monthly period (menstruation) when your bleeding gets in the way of social, leisure and physical activities. LYSTEDA does not contain any hormones and is taken only during your period. It does not treat premenstrual symptoms, does not affect your fertility, and cannot be used as birth control. It does not protect against sexually transmitted diseases.

LYSTEDA has not been studied in adolescents younger than 18 years of age.

Important Safety Information

You should not take LYSTEDA if you currently have or have ever had a blood clot, have been told you are at risk for having a blood clot, or are allergic to LYSTEDA or tranexamic acid.

LYSTEDA can cause serious side effects, including:

• The risk of serious blood clots may be increased when LYSTEDA is taken with hormonal contraceptives, especially if you are taking higher than your normal dose of birth control, are overweight, or if you smoke cigarettes. Risk of serious blood clots may also be increased if you take LYSTEDA with medicines used to help your blood clot or some medicines used to treat leukemia.
• Stop taking LYSTEDA and promptly report any eye problems to your healthcare provider.
• If you have shortness of breath and your throat feels tight, stop taking LYSTEDA and get medical help right away.

Before taking LYSTEDA, tell your healthcare provider about all of your medical conditions, including whether: you have ever had a blood clot or been told that you are at risk of having a blood clot, you are using a form of birth control that contains hormones, you are pregnant or think you may be pregnant, you are breastfeeding or plan to breast-feed, the time between the start of your periods is less than 21 days or more than 35 days, or you have any other medical conditions.

Tell your healthcare provider about all the medicines you take, especially if you take: birth control pills or other hormonal birth control, medicines used to help your blood clot, medicines used to break up blood clots, or any medicines to treat leukemia.

The most common side effects of LYSTEDA include: headaches, sinus and nasal problems, back pain, pain in your abdomen, pain in your muscles or joints, anemia, and fatigue.

If you notice a change in your usual bleeding pattern that worries you, or your heavy bleeding continues, contact your healthcare provider right away. This may be a sign of a more serious condition.

You are encouraged to report side effects of prescription drugs. Contact Ferring at 1-888-FERRING (1-888-337-7464) or call 1-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Full Prescribing Information »

Here are three women whose doctors decided LYSTEDA^® (tranexamic acid) was right for them.

These are actual LYSTEDA users. Your experience and results may vary.

	Ann’s Story Before LYSTEDA “Our family is big on camping, but that’s something I just wouldn’t do with heavy periods.” With LYSTEDA “I was able to just be outside and not have to constantly look for a restroom”
	Alisha’s Story Before LYSTEDA “I couldn’t do as much as I’d like to. It knocked me down for a couple of days.” With LYSTEDA “I’m able to function those first couple of days. I only have to take LYSTEDA when my menstrual cycle is here, so it’s easy.”
	Melany’s Story Before LYSTEDA “I definitely didn’t want to be going to any social activities. I had to wake up two times a night to change my protection.” With LYSTEDA “I’m so grateful there is something out there for people like me. It’s definitely worth asking your doctor about it. ”

WHAT IS LYSTEDA^®? LYSTEDA^® (tranexamic acid) tablets is a prescription medicine used to treat your heavy monthly period (menstruation) when your bleeding gets in the way of social, leisure and physical activities. LYSTEDA does not contain any hormones and is taken only during your period. It does not treat premenstrual symptoms, does not affect your fertility, and cannot be used as birth control. It does not protect against sexually transmitted diseases.

LYSTEDA has not been studied in adolescents younger than 18 years of age.

Important Safety Information

You should not take LYSTEDA if you currently have or have ever had a blood clot, have been told you are at risk for having a blood clot, or are allergic to LYSTEDA or tranexamic acid.

LYSTEDA can cause serious side effects, including:

• The risk of serious blood clots may be increased when LYSTEDA is taken with hormonal contraceptives, especially if you are taking higher than your normal dose of birth control, are overweight, or if you smoke cigarettes. Risk of serious blood clots may also be increased if you take LYSTEDA with medicines used to help your blood clot or some medicines used to treat leukemia.
• Stop taking LYSTEDA and promptly report any eye problems to your healthcare provider.
• If you have shortness of breath and your throat feels tight, stop taking LYSTEDA and get medical help right away.

Before taking LYSTEDA, tell your healthcare provider about all of your medical conditions, including whether: you have ever had a blood clot or been told that you are at risk of having a blood clot, you are using a form of birth control that contains hormones, you are pregnant or think you may be pregnant, you are breastfeeding or plan to breast-feed, the time between the start of your periods is less than 21 days or more than 35 days, or you have any other medical conditions.

Tell your healthcare provider about all the medicines you take, especially if you take: birth control pills or other hormonal birth control, medicines used to help your blood clot, medicines used to break up blood clots, or any medicines to treat leukemia.

The most common side effects of LYSTEDA include: headaches, sinus and nasal problems, back pain, pain in your abdomen, pain in your muscles or joints, anemia, and fatigue.

If you notice a change in your usual bleeding pattern that worries you, or your heavy bleeding continues, contact your healthcare provider right away. This may be a sign of a more serious condition.

You are encouraged to report side effects of prescription drugs. Contact Ferring at 1-888-FERRING (1-888-337-7464) or call 1-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Full Prescribing Information »

Ferring Web Site Usage Terms

PLEASE READ AND REVIEW THE FOLLOWING TERMS AND CONDITIONS CAREFULLY BEFORE USING THIS WEB SITE. By using this web site, you agree to these terms and conditions. If you do not agree, please exit and disregard the information contained herein.

General Information

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

Ferring maintains this web site for your personal use. This web site and its contents are intended to comply with the laws and regulations of the U.S. While you can access this web site from outside the U.S., our server is located within the U.S., and the web site it is intended to be used by residents located in the U.S.

Medical Information/Conditions

Please note that product information presented on this website is intended only as a brief summary for the visitor's convenience in relation to the activities of Ferring. Not all products or indications are licensed in every country and may be subject to further local variations.

While there may be information on this web site related to certain medical conditions and their treatment, should a medical condition exist, promptly see your own physician or health provider. Ferring does not offer personalised medical diagnosis or patient-specific treatment advice. Indeed, only your doctor or other health care professional, as a learned intermediary, can determine if a product described in this web site is appropriate for you.

PLEASE CONSULT WITH YOUR DOCTOR, OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL BEFORE USING ANY PRODUCT DISCUSSED WITHIN THIS WEB SITE.

Copyright And Restriction On Use Of Material (Noncommercial Use)

This web site is copyright protected. Any textual or graphic material you copy, print, or download from this web site is licensed to you by Ferring and/or its subsidiaries for your personal, noncommercial home use only, provided that you do not change or delete any copyright, trademark or other proprietary notices.

Limitation of Liability

Ferring will use reasonable efforts to include accurate, complete and up-to-date information on this web site, but Ferring makes no warranties or representations as to its accuracy, completeness or frequency that it is updated. All users agree that access to this web site is at their own risk, and that neither Ferring nor any party involved in creating or delivering this web site shall be liable for damages of any kind, including without limitation, any special, direct or indirect, incidental, or consequential or punitive damages (even if Ferring has been advised of the possibility of such damages) arising out of access to, or use of the information contained on this web site, or any errors or omissions, misprints, out-of-date information, technical or pricing inaccuracies, typographical or other errors appearing on this web site. This limitation includes damages to, or for any viruses that may infect, your computer equipment.

Dispute Resolution

All legal disputes arising out of or in connection with this web site (including without limitation, disputes regarding usage of personal information provided to Ferring via the web site) which can not be resolved through good faith discussions, shall be referred to and finally determined by arbitration as follows. The Arbitration Tribunal shall comprise three arbitrators. Each party shall appoint one arbitrator and the two arbitrators so appointed shall appoint the third arbitrator. The third arbitrator shall be a member of the legal profession. If either party fails to appoint its arbitrator within on month of the receipt of a corresponding request by the other, or if the two arbitrators appointed fail to reach agreement on the third arbitrator within one month of the date of the last appointment, that arbitrator and/or the third arbitrator shall, at the request of either party, be appointed by the American Arbitration Association. The Arbitration Tribunal shall sit in New York, New York and the arbitration proceedings shall be conducted in English. The arbitration proceedings shall be governed by the rules of civil procedure applicable in the State of New York.

Disclaimer

Information and related materials are subject to change without notice. This web site, and all information and related materials it contains, are provided "as is." Ferring makes no representation or warranty whatsoever regarding the completeness, accuracy, "up-to-dateness", or adequacy of, or the suitability, functionality, availability, or operation of this web site or the information or materials it contains. By using this web site, you assume the risk that the information and materials on this web site may be incomplete, inaccurate, out of date, or may not meet your needs and requirements. Ferring specifically disclaims all warranties, express or implied, including without limitation, the warranties or merchantability, fitness for a particular purpose, and non-infringement with respect to this web site and information, graphics and materials contained herein.

Links to Other Web Sites

This web site may contain links to, or be accessed from links on, other world wide web sites. Ferring does not have responsibility for, or control of, the contents, availability, operation or performance of other web sites to which this web site may be linked or from which this web site may be accessed. Ferring makes no representation regarding the content of any other web sites which you may access from this web site.

Concerning Your Privacy

Access to this web site may be monitored by Ferring. If monitored, the requesting URLs, the machine originating the request, and the time of the request, are logged for access statistics and security purposes. Your use and access of this web site constitutes your consent to such general monitoring. Please see FERRING PRIVACY POLICY for details on how information from the web site may be gathered and used.

Trademarks

All trademarks, logos and service marks appearing in this web site, and as designated with either a trademark symbol or type form that is different from the surrounding text, are trademarks owned by or licensed to Ferring, its subsidiaries or affiliates. Notwithstanding this disclaimer, all other names and marks mentioned in this web site are the trade names, trademarks or service marks of their respective owners.

No License

Nothing in this web site shall be construed as conferring by implication, estoppel or otherwise, any license or right to use in any form or manner any patent, copyright or trademark of Ferring. Please be advised that Ferring protects its intellectual property rights to the fullest extent of the law.

Submissions (Information To Ferring)

The submission of any unsolicited information, such as questions, comments, or suggestions, to Ferring, either through this web site or by any other means of communication, shall NOT be considered confidential. Ferring shall have no obligation to you of any kind with respect to such information. By submitting any information to Ferring, you understand that Ferring shall be free to reproduce, use, disclose, display, exhibit, transmit, perform, create derivative works, and distribute the information to others without limitation, and to authorise others to do the same. In addition, Ferring shall be free to use any ideas, concepts, know-how or techniques contained in such information for any purpose whatsoever, including but not limited to, developing, manufacturing and marketing products and other items incorporating such ideas, concepts, know-how or techniques.

Other

This agreement shall be governed by and construed in accordance with laws of the U.S. If any provision of this agreement is held to be unlawful, void, or for any reason unenforceable, then that provision shall be eliminated or limited to the minimum extent necessary and such elimination or limitation shall not affect the validity and enforceability of any remaining provisions. This is the entire agreement between the parties relating to the subject matter herein and you agree to indemnify Ferring for any claims or damages resulting from your failure to abide by these terms and conditions.

The Ferring web site may be unavailable from time to time due to mechanical, telecommunication, software, hardware and third-party vendor failures, updating or construction. Ferring cannot predict or control when such downtime may occur and cannot control the duration of such downtime.

Ferring reserves the right to alter or delete material from this web site at any time.

Ferring may, at any time, revise these Web site Usage Terms by updating this posting. You are bound by any such revisions and should, therefore, periodically review these terms to review the then current Usage Terms.

LYSTEDA^® (tranexamic acid) tablets is a prescription medicine used to treat your heavy monthly period (menstruation) when your bleeding gets in the way of social, leisure and physical activities. LYSTEDA does not contain any hormones and is taken only during your period. It does not treat premenstrual symptoms, does not affect your fertility, and cannot be used as birth control. It does not protect against sexually transmitted diseases.

LYSTEDA has not been studied in adolescents younger than 18 years of age.

Important Safety Information

You should not take LYSTEDA if you currently have or have ever had a blood clot, have been told you are at risk for having a blood clot, or are allergic to LYSTEDA or tranexamic acid.

LYSTEDA can cause serious side effects, including:

• The risk of serious blood clots may be increased when LYSTEDA is taken with hormonal contraceptives, especially if you are taking higher than your normal dose of birth control, are overweight, or if you smoke cigarettes. Risk of serious blood clots may also be increased if you take LYSTEDA with medicines used to help your blood clot or some medicines used to treat leukemia.
• Stop taking LYSTEDA and promptly report any eye problems to your healthcare provider.
• If you have shortness of breath and your throat feels tight, stop taking LYSTEDA and get medical help right away.

Before taking LYSTEDA, tell your healthcare provider about all of your medical conditions, including whether: you have ever had a blood clot or been told that you are at risk of having a blood clot, you are using a form of birth control that contains hormones, you are pregnant or think you may be pregnant, you are breastfeeding or plan to breast-feed, the time between the start of your periods is less than 21 days or more than 35 days, or you have any other medical conditions.

Tell your healthcare provider about all the medicines you take, especially if you take: birth control pills or other hormonal birth control, medicines used to help your blood clot, medicines used to break up blood clots, or any medicines to treat leukemia.

The most common side effects of LYSTEDA include: headaches, sinus and nasal problems, back pain, pain in your abdomen, pain in your muscles or joints, anemia, and fatigue.

If you notice a change in your usual bleeding pattern that worries you, or your heavy bleeding continues, contact your healthcare provider right away. This may be a sign of a more serious condition.

You are encouraged to report side effects of prescription drugs. Contact Ferring at 1-888-FERRING (1-888-337-7464) or call 1-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Full Prescribing Information »